Patents
Patents for C07C 219 - Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton (3,521)
07/2004
07/15/2004WO2004058682A1 Selective estrogen receptor modulators
07/15/2004WO2004045536A3 Method and compositions for temporarily incapaciting subjets
07/14/2004EP1435930A2 Anti-glycation agents for preventing age-, diabetes-, and smoking-related complications
07/14/2004CN1157366C Dimethyl-(3-aryl-but-3-enyl)-amine compounds as pharmaceutical active ingredients
07/13/2004US6762175 Fatty acid derivatives
07/08/2004US20040132796 Novel intermediates for use in retinoid synthesis
07/07/2004CN1510024A Compound for preparing citalopram enantiomer and its production
07/01/2004US20040127564 inactivators of antigen-specific T cells; increased half-life
06/2004
06/29/2004US6756047 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
06/17/2004US20040116519 Anticholinergic agents such as 4-(diethylmethylaminium)-2-butynyl alpha phenyl cyclohexane glycolate iodide, used for prophylaxis of asthma, chronic obstructive pulmonary disease and rhinitis
06/16/2004EP0977725B1 New fatty acid derivatives
06/15/2004US6750238 Aralkyl ester soft drugs
06/10/2004US20040110984 Two-photon or higher-order absorbing optical materials for generation of reactive species
06/09/2004CN1502612A Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
06/08/2004US6747164 Esteramines derived from an ethoxylated alcohol that has been carboxymethylated, then esterified with a tertiary hydroxyamine; amidoamines are from a fatty acid or a fatty acid methyl ester and a diamine; fungicide; insecticide
06/08/2004US6746711 Polymers with biocidal action, process for their preparation and their use
06/08/2004CA2102490C 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them
06/03/2004WO2004045536A2 Method and compositions for temporarily incapaciting subjets
06/03/2004WO2004045533A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
06/03/2004CA2503316A1 Method and compositions for temporarily incapacitating subjects
06/03/2004CA2503312A1 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
06/02/2004EP1424321A1 Synthesis of optically active cyclohexylphenylglycolate esters
06/02/2004EP1423354A1 Synthesis of alkylaminoalkyl (meth)acrylate by transesterification
05/2004
05/27/2004WO2004043921A1 Novel process for the preparation of 4-aryl-3-hydroxymethyl-1-methylpiperidines.
05/27/2004US20040102652 For treatment of cardiovascular disorders/heart failure
05/20/2004US20040097755 Ionic liquids and their use as solvents
05/13/2004WO2004039763A1 Quaternary ammonium compounds
05/13/2004US20040092764 Method for preparing amino alkyl(meth)acrylates
05/13/2004CA2498189A1 Quaternary ammonium compounds
05/11/2004US6734316 Such as ethyl-n-(2-(4-((cis-2-octadecanoyloxycyclohexyl) methyl)pheynoxy)ethyl)carbamate for insect population density control
05/06/2004US20040087632 Controlling metabolism of lipids, cholesterol
05/06/2004EP1021501A4 Cationic detergent compounds
04/2004
04/29/2004US20040082683 Dental materials with extendable work time, kits, and methods
04/29/2004CA2501990A1 Cationic cardiolipin analogs and use thereof
04/28/2004EP1412613A1 Additives for inhibiting the formation of gas hydrates
04/28/2004CN1147461C 3-amino-3-aryl-1-alcohol derivatives and preparation and use thereof
04/28/2004CN1147459C Galcium receptor-active compound
04/21/2004EP1192123B1 Novel monomers with quaternary amino groups, method for making same, and novel (co)polymers obtained from said novel monomers
04/21/2004EP1159257B1 Esterquats, their intermediates, a process to make the esterquats, and their use
04/20/2004US6723753 Substituted n-benzyl-n-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
04/14/2004EP1100772B1 Open chain alkoxyamine compounds and their use as polymerization regulators
04/14/2004EP1019361B1 Polyfunctional cationic cytofectins, formulations and methods for generating active cytofectin:polynucleotide transfection complexes
04/14/2004EP0724561B1 Calcium receptor-active arylalkyl amines
04/08/2004WO2004029004A1 Compositions containing ionic liquids and uses thereof, especially in organic synthesis
04/08/2004US20040067981 Acetylcholinesterase inhibitor; Alzheimer's diseases, Hubtington disease, antidepressants
04/08/2004CA2500206A1 Compositions containing ionic liquids and uses thereof, especially in organic synthesis
04/07/2004EP1404641A1 Crystalline form of a phenylethanolamine, the preparation thereof and pharmaceutical compositions comprising the same
04/01/2004WO2004027789A1 Composition for polyelectrolytes, polyelectrolytes, electrical double layer capacitors and nonaqueous electrolyte secondary cells
04/01/2004WO2004026817A1 Amino alcohol derivative, addition salt thereof, and immunosuppressant
04/01/2004US20040063677 Omega monounsaturated fatty acid derivativatized biologically active materials; drug delivery; drug resistance; bioavail-ability
04/01/2004CA2499553A1 Composition for polyelectrolytes, polyelectrolytes, electrical double layer capacitors and nonaqueous electrolyte secondary cells
03/2004
03/31/2004EP1185498B1 Synthesis of optically active cyclohexylphenylglycolic acid and its esters
03/31/2004EP0937030B1 3-amino-propoxyphenyl derivatives (i)
03/30/2004US6713464 Derivatives of 3,3-diphenylpropylamines
03/25/2004US20040058346 Polynucleotide cleavage agent switched on by photo irradiation
03/24/2004EP1399409A1 Method for producing (meth)acrylic acid esters
03/24/2004EP1399408A1 Method for producing (meth)acrylic acid esters
03/24/2004EP0981512B1 Quaternary fatty acid triethanolamine ester salts and their use as fabric softeners
03/24/2004CN1142904C One-step process synthetizing 2-oxazolidone derivative interediate and preparation process thereof
03/23/2004US6710089 Substituted N-fused-phenyl-N-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
03/18/2004WO2003047499A3 Amphiphilic compounds and vesicles/liposomes for organ-specific drug targeting
03/11/2004WO2003088915A3 Novel sodium channel blockers
03/11/2004US20040048834 Antitumoral compounds
03/09/2004US6703468 Composition for topical administration to skin or hair comprising suitable carrier and effective amount of specified polymer which has beneficial effects on skin functions
03/04/2004US20040044061 Analgesics; side effect reduction
03/03/2004EP1392637A2 Modulators of peroxisome proliferator activated receptors
03/03/2004CN1140499C Stabilized aqueous solutions of unsaturated quaternary ammonium salts
03/03/2004CN1140497C Method for making aqueous solutions of unsaturated quaternary ammonium salts
03/02/2004US6699898 Method of treating coronary artery disease or other cetp-mediated disorders in a subject by administering a therapeutically effective amount of a compound of one of claims
02/2004
02/26/2004WO2004016579A1 Method for producing 3-amino-4,4,4-trifluorocrotonic acid esters
02/26/2004DE10237285A1 Production of 3-amino-4,4,4-trifluorocrotonate ester for use in synthesis of plant protection agents involves reacting alkyl trifluoroacetate with alkyl acetate and metal alcoholate to form an enolate which is then reacted with amine
02/26/2004DE10237031A1 New quaternary fatty acid alkanolamine ester salts, useful e.g. as emulsifiers or in textile brighteners or cosmetics, have their fatty acid components derived from conjugated linoleic acid
02/24/2004US6696472 Substituted N-phenoxy-N-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
02/24/2004US6696435 For treating atherosclerosis, other coronary artery diseases; 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for example
02/12/2004WO2004013086A1 Photoactive materials
02/12/2004WO2004013083A1 Nolomirole hydrochloride form i
02/12/2004US20040029963 Use of pamoic acid or one of its derivatives, or one of its analogues , for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
02/12/2004US20040029929 Aminoadamantane derivatives as therapeutic agents
02/10/2004US6689899 Diamine and acid anhydride
02/05/2004US20040024242 By reaction, in the presence of water, of N,N-dimethylaminoethyl (meth)acrylate with benzyl chloride, continuously in a reactor operating according to perfectly stirred reactor technology
02/05/2004US20040024057 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use related applications
02/04/2004EP1386910A1 Photoactive materials
01/2004
01/29/2004WO2004009034A2 Thiomolybdate analogues and uses thereof
01/29/2004US20040019087 Thiomolybdate analogues and uses thereof
01/29/2004US20040019043 Thiomolybdate analogues and uses thereof
01/29/2004CA2493127A1 Thiomolybdate analogues and uses thereof
01/28/2004EP1384708A1 Process for the manufacture of form I of nolomirole hydrochloride
01/28/2004EP1383730A2 Anticholinergic compounds and methods of use
01/28/2004CN1136189C Substituted heterocyclic compounds, preparing method thereof and pharmaceutical composition containig them
01/27/2004US6683203 Process for the manufacture of aqueous solutions of unsaturated quaternary ammonium salts
01/27/2004US6683099 Substituted N,N-disubstituted cycloalkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
01/21/2004EP1382333A2 Use of beta 3 adrenergic receptor agonists in the treatment of dysuria
01/15/2004WO2004004648A2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
01/15/2004US20040010038 Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors
01/15/2004CA2491127A1 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
01/13/2004US6677382 Halogenated oxyamines, used as enzyme inhibitors for prophylaxis of atherosclerosis and cardiovascular disorders, and as antilipemic agents
01/13/2004US6677380 Antilipemic agents such as 3(3-(4-chloro-3-ethyl-phenoxy)-phenyl)((3-(1,1,2,2 -tetrafluoroethoxy)phenyl)methyl))amino)-1,1,1-trifluro-2-propanthiol, used for prophlaxis of cardiovascular disorders and atherosclerosis
01/13/2004US6677379 Such as 3-((3-(3-trifluoromethoxyphenoxy)phenyl)((3-(1,1,2,2-tetrafluoroethoxy) -phenyl)methyl) amino)-1,1,1-trifluoro-2-propanol for treatment of coronary artery disease
01/13/2004US6677375 Substituted N,N-bis-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
01/13/2004US6677353 Substituted N-phenyl-N-heteroaralkyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 36